IL17A and esophageal cancer: Similarly, in the field of esophageal cancer, IL-17A can not only promote the invasion of tumor cells (Liu et al., 2017), but also induce anti-tumor immunity by recruiting and activating beneficial B cells and neutrophils (Chen et al., 2017; Lu et al., 2016).